Skip to main content

Table 1 Triple negative cell lines used in the studies based on their p53 and BRCA1 mutation status

From: Therapy response testing of breast cancer in a 3D high-throughput perfused microfluidic platform

Cell line BRCA1 status1 P53 status2
MDA-MB-453 WT 367 30 bp deletion
MDA-MB-231 WT 280 Arg - > Lys
HCC1937 5382insC (fs > 1829X) 306 Arg - > stop